Medicare now covers screening for Hepatitis B Virus (HBV) infection, effective for services on or after Sept. 28, 2016. Practices should be aware that Medicare coinsurance and the Part B deductible are waived for this preventive service.
Medicare will cover screening for HBV infection, when ordered by the beneficiary’s primary care physician or practitioner within the context of a primary care setting, and performed by an eligible Medicare provider for these services, within the context of a primary care setting if the screening is:
- Performed with the appropriate U.S. Food and Drug Administration (FDA) approved/cleared laboratory tests.
- Used consistent with FDA-approved labeling.
- In compliance with the Clinical Laboratory Improvement Act (CLIA) regulations.